SCHEMBL12813495

SCHEMBL12813495

COc1ccc(C(O)C2=C(C)CCCC2(C)C)cc1F

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.39
▸ CYP11B1 P15538 2/20 0.39
▸ CYP11B2 P19099 2/20 0.39
▸ LMNA P02545 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ PDCD1 Q15116 1/20 0.34
▸ ACE2 Q9BYF1 1/20 0.34
▸ CD274 Q9NZQ7 1/20 0.34
▸ HSD11B1 P28845 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ CREBBP Q92793 1/20 0.33
▸ UGCG Q16739 1/20 0.32
▸ PTGS2 P35354 1/20 0.32
▸ TUBB1 Q9H4B7 2/20 0.32
▸ KDM1A O60341 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12813282 0.88 SLC6A2 (0.38) CYP3A4LMNAPDCD1ACE2CD274
SCHEMBL16498935 0.87 PDE2A (0.45) —
SCHEMBL12813382 0.86 HSD11B1 (0.34) CYP3A4CYP11B1CYP11B2HSD11B1
SCHEMBL12813325 0.80 CES2 (0.32) LMNA
SCHEMBL12813503 0.80 SLC6A4 (0.36) CYP3A4PTGS2
SCHEMBL16499126 0.80 CYP11B1 (0.36) CYP11B1CYP11B2KDM1A
SCHEMBL12813191 0.79 KMT2A (0.33) KMT2AHSD11B1
SCHEMBL12813698 0.78 RXRA (0.33) —
SCHEMBL12813187 0.78 SLC6A2 (0.42) HSD11B1BRD4
SCHEMBL12813356 0.77 TSHR (0.41) KMT2AMEN1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012134971-A2 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS, INC. (US) 2012-10-04 — — WO disclosed
WO-2011155983-A1 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS INC. (US) 2011-12-15 — — WO disclosed
Send feedback